Search Results 3301-3310 of 11175 for cannabis
Title: Long-Term Treatment and Follow Up of Subjects Completing 24 Months of Treatment with Tesevatinib on Study KD019-101 in Subjects with Autosomal ...
Thousands of Americans suffer from thumb arthritis. This disorder can greatly affect daily life and can make it a struggle to do simple things like[...] ...
ROCHESTER, Minn. — Researchers from the Mayo Clinic Comprehensive Cancer Center are set to present key research findings, including two late-breaking ...
The breakneck pace of genomic discoveries has ushered in a new problem in the delivery of personalized medicine: comprehensive and consistent data reporting ...
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine. Donate · Find a doctor · Explore careers.
DEAR MAYO CLINIC: My kids and I love to go hiking when the weather is nice, but I've heard ticks are terrible this year. What[...].
The purpose of this study is to evaluate the safety, dose, immunogenicity and early clinical activity of GRT-C901 and GRT-R902, a personalized neoantigen ...
When it comes to back pain, there's good news and bad news. The good news is that back pain is rarely a sign of something[...] ...
Title: A Phase III, Randomized, Open Label Trial of Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin as First Line ...
MONDAY HOUSECALL: Psoriasis, Incontinence, Burning Mouth Syndrome and more … Dana Sparks. February 18, 2013. Milroy Syndrome.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.